Evaluation of optical coherence tomography in the diagnosis of age related macula degeneration compared with fluorescence angiography.

GMS health technology assessment Pub Date : 2007-02-20
Heidi Stürzlinger, Dieter Genser, Barbara Fröschl
{"title":"Evaluation of optical coherence tomography in the diagnosis of age related macula degeneration compared with fluorescence angiography.","authors":"Heidi Stürzlinger,&nbsp;Dieter Genser,&nbsp;Barbara Fröschl","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In industrialised nations age-related macular degeneration (AMD) is the most common cause of blindness and severe visual impairment. AMD is a disease of the retina characterized by the accumulation of metabolic products in the macula. In early stages drusen and pigment disorders occur, in late stages a dry form is distinguished from the exsudative form with choroidal neovascularisation. AMD causes vision disorders such as blurred vision of the central part of the visual field, leading finally to a dark spot. Several therapies are available for the exsudative form, however an exact diagnosis is partially essential. The gold standard for the diagnosis of AMD is fluorescein angiography (FA), an invasive investigation with intravenous application of a dye. Optical coherence tomography (OCT) is a more recent non-invasive procedure.</p><p><strong>Objectives: </strong>The aim of this HTA report is to investigate the efficacy and efficiency of OCT compared to FA. Ethical, societal and legal aspects are also considered.</p><p><strong>Methods: </strong>A systematic literature search was performed in 34 international databases which yielded 2324 articles. Eight publications were included for assessment, according to predefined selection criteria.</p><p><strong>Results: </strong>The number of studies investigating OCT compared to FA in patients with AMD is presently very limited and the quality of the studies is generally low. The number of investigated patients is below 35 in four publications and in only one publication it is above 100. Moreover in most of the articles very selected patient groups are studied. Economic studies concerning the efficiency of OCT compared to FA cannot be identified.</p><p><strong>Discussion: </strong>Even though the patient groups investigated and the objectives of the studies are very heterogenous, all publications uniformly show that OCT cannot replace FA. However, OCT yields additional diagnostic findings and may verify unclear findings of FA. Therefore the application of OCT in addition to FA is useful in many cases. With regard to costs German patients on average currently have to pay more for performing OCT than for performing FA.</p><p><strong>Conclusion: </strong>Future studies have to show whether OCT may give diagnostic information essential for therapeutic decisions in addition to FA and whether it can replace FA in selected cases. The number of patients included in these studies should be high enough to answer relevant questions with sufficient statistical power. An economic model calculation can be built upon the resulting findings.</p>","PeriodicalId":89142,"journal":{"name":"GMS health technology assessment","volume":"3 ","pages":"Doc02"},"PeriodicalIF":0.0000,"publicationDate":"2007-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/86/c1/HTA-03-02.PMC3011331.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"GMS health technology assessment","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: In industrialised nations age-related macular degeneration (AMD) is the most common cause of blindness and severe visual impairment. AMD is a disease of the retina characterized by the accumulation of metabolic products in the macula. In early stages drusen and pigment disorders occur, in late stages a dry form is distinguished from the exsudative form with choroidal neovascularisation. AMD causes vision disorders such as blurred vision of the central part of the visual field, leading finally to a dark spot. Several therapies are available for the exsudative form, however an exact diagnosis is partially essential. The gold standard for the diagnosis of AMD is fluorescein angiography (FA), an invasive investigation with intravenous application of a dye. Optical coherence tomography (OCT) is a more recent non-invasive procedure.

Objectives: The aim of this HTA report is to investigate the efficacy and efficiency of OCT compared to FA. Ethical, societal and legal aspects are also considered.

Methods: A systematic literature search was performed in 34 international databases which yielded 2324 articles. Eight publications were included for assessment, according to predefined selection criteria.

Results: The number of studies investigating OCT compared to FA in patients with AMD is presently very limited and the quality of the studies is generally low. The number of investigated patients is below 35 in four publications and in only one publication it is above 100. Moreover in most of the articles very selected patient groups are studied. Economic studies concerning the efficiency of OCT compared to FA cannot be identified.

Discussion: Even though the patient groups investigated and the objectives of the studies are very heterogenous, all publications uniformly show that OCT cannot replace FA. However, OCT yields additional diagnostic findings and may verify unclear findings of FA. Therefore the application of OCT in addition to FA is useful in many cases. With regard to costs German patients on average currently have to pay more for performing OCT than for performing FA.

Conclusion: Future studies have to show whether OCT may give diagnostic information essential for therapeutic decisions in addition to FA and whether it can replace FA in selected cases. The number of patients included in these studies should be high enough to answer relevant questions with sufficient statistical power. An economic model calculation can be built upon the resulting findings.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
光学相干断层扫描与荧光血管造影对年龄相关性黄斑变性诊断的评价。
背景:在工业化国家,年龄相关性黄斑变性(AMD)是导致失明和严重视力障碍的最常见原因。黄斑变性是一种视网膜疾病,其特征是黄斑中代谢产物的积累。在早期阶段,出现色素性和色素紊乱,在晚期,干燥形式与脉络膜新生血管的渗出形式区别开来。AMD会引起视觉障碍,如视野中心部分视力模糊,最终导致黑斑。有几种治疗方法可用于渗出形式,但准确的诊断是部分必要的。AMD诊断的金标准是荧光素血管造影(FA),这是一种静脉应用染料的侵入性检查。光学相干断层扫描(OCT)是一种较新的非侵入性手术。目的:本HTA报告的目的是探讨OCT与FA的疗效和效率。伦理、社会和法律方面也被考虑在内。方法:系统检索国际34个数据库,共收录文献2324篇。根据预先确定的选择标准,纳入了8份出版物进行评估。结果:目前研究OCT与FA在AMD患者中的比较的研究数量非常有限,研究质量普遍较低。在四篇出版物中,调查的患者数量低于35例,只有一篇出版物的调查患者数量高于100例。此外,在大多数文章中,非常选定的患者群体进行了研究。关于OCT与FA相比效率的经济学研究无法确定。讨论:尽管调查的患者群体和研究的目的非常不同,但所有的出版物都一致表明OCT不能取代FA。然而,OCT可提供额外的诊断结果,并可能证实FA的不明确表现。因此,除FA外,OCT的应用在许多情况下都是有用的。在费用方面,德国患者目前平均需要为OCT支付比FA更多的费用。结论:未来的研究必须表明OCT是否可以提供除FA之外的诊断信息,以及它是否可以在选定的病例中替代FA。纳入这些研究的患者数量应足够高,以足够的统计力回答相关问题。经济模型计算可以建立在结果的基础上。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Variability in the prescription of drugs with uncertain effectiveness. The case of SYSADOA in the Basque Country. Q-SEA - a tool for quality assessment of ethics analyses conducted as part of health technology assessments. Effects of continuous and intermittent renal replacement therapies among adult patients with acute kidney injury. Telemedicine: The legal framework (or the lack of it) in Europe. Complex health care interventions: Characteristics relevant for ethical analysis in health technology assessment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1